Sunday, December 14, 2025 | 11:01 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

USFDA completes inspection of Dr Reddys' API Hyderabad Plant 3

Image

Capital Market

Receives 5 observations under Form 483

Dr Reddys Laboratories announced that the audit of its API Hyderabad Plant 3 at Bollaram, Medak District, Telangana by the USFDA has been completed on 09 March 2018. The company has been issued a Form 483 with five observations.

Powered by Capital Market - Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 09 2018 | 6:11 PM IST

Explore News